Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-09-23FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Leuprolide acetate from Amneal Pharmaceuticals LLC, granting approval for a generic version of t…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency [Phase 2]
Phase 2 clinical trial assessing interventions to improve quality of life in prostate cancer survivors with androgen deficiency; the study h…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028 [Phase 3]
A Phase 3 clinical trial update for the 18F-PSMA-1007 PET/CT imaging in prostate cancer (ACCESS Trial), planned from 2022 to 2028, currently…
-
CLINICAL_TRIALS withdrawal · 2025-09-23Clinical Trial Update: Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab with androgen deprivation therapy and radiotherapy for high-risk localized prostate cancer has been…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: RElugolix VErsus LeUprolide Cardiac Trial [Phase 2]
Phase 2 trial comparing Relugolix to Leuprolide in biochemically recurrent and localized prostate cancer; results have been posted as of 202…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer [Phase 2]
This Phase 2 trial evaluating sequential oral testosterone undecanoate followed by enzalutamide in men with metastatic castration-resistant …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients
This clinical trial update reports a completed study on positron emission radiomics using PSMA radioligands in newly diagnosed prostate canc…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients [NA]
This clinical trial update discusses the use of two gallium-68 PET tracers, 68Ga-P16-093 and 68Ga-PSMA-11, in the same group of patients wit…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer [NA]
Status update for a prospective safety and efficacy study of lesion-targeted MRI-TULSA in localized prostate cancer; the trial is currently …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
This clinical trial update outlines a prospective database studying outcomes after cryotherapy for clinically localized prostate cancer. The…
-
FDA approval · 2025-09-19FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc)
FDA approved a supplemental application for Leuprolide acetate from Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors [Phase 3]
This is a Phase 3 clinical trial evaluating intermittent androgen deprivation therapy for prostate cancer in the era of AR pathway inhibitor…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Precise Oncology Interventions in Nutrition and Training (OnPoint) [NA]
The OnPoint clinical trial from the University of Miami is evaluating precise oncology interventions in nutrition and training; it is curren…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE
This clinical trial entry describes a study on chlordecone exposure and prostate cancer in Martinique (French region), which is not yet recr…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer [Phase 2]
Clinical trial update for a Phase 2 study comparing ODM-201 with androgen deprivation therapy in men with hormone-naive prostate cancer; the…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Improving Care After Inherited Cancer Testing [NA]
A Vanderbilt-Ingram Cancer Center trial aimed at improving care after inherited cancer testing is active but not recruiting, studying patien…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System
Post-marketing follow-up study of the BioProtect Balloon Implant System for prostate cancer; the trial is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC) [Phase 2]
Phase 2 clinical trial evaluating Sacituzumab Tirumotecan in combination with Tagitanlimab for aggressive variant and neuroendocrine prostat…
-
CLINICAL_TRIALS withdrawal · 2025-09-17Clinical Trial Update: Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer
This clinical trial update reports that the study assessing circulating and intratumoral chemokines in patients with prostate cancer has bee…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer [Phase 2]
Phase 2 clinical trial comparing high-dose-rate brachytherapy versus stereotactic ablative radiotherapy as monotherapy for localized prostat…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients
This study provides a retrospective evaluation of commercially available spacers used in prostate cancer patients undergoing radiotherapy, d…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
This clinical trial update describes a study assessing changes in the urinary and gut microbiome in prostate cancer patients undergoing andr…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy. [NA]
A clinical trial investigating personalized radiotherapy for biochemical recurrence of prostate cancer after prostatectomy is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Prospective Evaluation of a Commercially Available Hydrogel Spacer
Sponsored by BioProtect, this prospective evaluation of a commercially available hydrogel spacer for prostate cancer radiotherapy has comple…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy [NA]
This clinical trial investigates PSMA PET/MRI-guided prostate biopsy for men with PI-RADS 3 or less and a prior negative biopsy and is curre…